Misconceptions about psoriatic arthritis can make it difficult to diagnose and explain to others.

Psoriasis, affecting over a million people across Britain, may put those living with the condition and their family members ...

NEW YORK (Reuters Health) - As many as 14 percent of people with psoriasis may also have psoriatic arthritis, research shows. Psoriatic arthritis is an autoimmune disorder that combines symptoms of ...

Otezla (apremilast) is an oral tablet commonly used to treat psoriatic arthritis in adults. Psoriatic arthritis is a long-lasting condition that affects the joints in people with psoriasis. Common ...

Three months after Bristol Myers Squibb revealed the success of two phase 3 trials of its oral targeted therapy Sotyktu in psoriatic arthritis (PsA), the company has presented detailed data from one ...

Psoriatic arthritis (PsA) is an autoimmune disease that causes inflammation of the skin, joints, tendons, and nails. It can cause pain, swelling, stiffness, and reduced range of motion. Treatment of ...

Early results of an international study examining the risk of arthritis for people with psoriasis have shown a high burden of joint symptoms in 712 patients – 25% of the total studied so far. The ...

Please provide your email address to receive an email when new articles are posted on . Selarsdi is approved for the treatment of plaque psoriasis, psoriatic arthritis in adults, patients aged 6 years ...

Depression symptoms are often underdiagnosed and undertreated in patients with psoriasis and psoriatic arthritis, contributing to a worsened quality of life (QOL). However, a recent study found that ...

European regulators have recommended expanding use of the IL-23 inhibitor Skyrizi to treat moderate-to-severe plaque psoriasis in children aged 6 years or older who require systemic therapy.

One of the more serious side effects from immune checkpoint inhibitor (ICI) therapies for cancer is new-onset or worsened autoimmune diseases. Clinicians have been concerned that conventional ...